Dr. Brian Alexander, CEO of Foundation Medicine, explains the company’s rationale for partnering with TargetCancer Foundation on the TRACK study. Dr. Alexander shared these thoughts during 2020 Rare Cancer Day 2020.
Dr. Brian Alexander, CEO of Foundation Medicine, explains the company’s rationale for partnering with TargetCancer Foundation on the TRACK study. Dr. Alexander shared these thoughts during 2020 Rare Cancer Day 2020.